Last updated: July 5, 2026

Aetna Connecticut Weight Loss Treatment Coverage | Klarity Health

If you have Aetna insurance in Connecticut and are exploring options for medically supervised weight loss, understanding what your plan may cover can help you take the next step with confidence. Aetna plans available in Connecticut may cover online weight loss treatment including prescription medications and telehealth consultations, though coverage details vary significantly by plan type, employer group, and formulary tier.

Check if your Aetna plan may cover weight loss treatment in Connecticut →

See if you may qualify for online weight loss treatment at Klarity Health →

Weight Loss Coverage and Connecticut Insurance Law

Connecticut’s mental health and substance use parity law — CGS § 38a-514b — requires fully insured health plans regulated by the Connecticut Insurance Department (CID) to cover behavioral health conditions at parity with medical and surgical benefits. While CGS § 38a-514b does not mandate direct coverage of weight loss medications as a category, obesity has well-documented behavioral health comorbidities that bring it within parity protections in many clinical contexts.

In practice, Aetna-insured patients in Connecticut who carry diagnoses of binge eating disorder (BED), depression with weight gain as a symptom, anxiety disorders with metabolic impact, or other DSM-5 behavioral health conditions linked to obesity may be entitled to parity-protected coverage for the behavioral health component of their treatment. Clinicians at Klarity Health can assess and document these comorbidities, which may strengthen a prior authorization submission or appeal.

Connecticut also has a separate telehealth parity law that requires insurers to reimburse telehealth-delivered services at the same rate as in-person care, meaning your Aetna plan may not impose additional cost-sharing solely because your weight loss consultation occurs via telehealth.

For plan-level guidance, you can contact the Connecticut Insurance Department (CID) at 1-800-203-3447 or visit Access Health CT (the state’s official health insurance marketplace) to review plan documents and compare benefits before enrolling.

Important note: Self-funded employer plans (ERISA plans) are governed by federal ERISA law rather than Connecticut state insurance regulations. CGS § 38a-514b does not apply to ERISA-governed plans. If your Aetna coverage comes through a large employer, your plan documents and the federal Mental Health Parity and Addiction Equity Act (MHPAEA) govern your rights instead.

Does Aetna Cover Weight Loss Medication in Connecticut?

Aetna uses CVS Caremark as its pharmacy benefit manager (PBM) for most commercial plans. This means your weight loss medication formulary — the list of covered drugs and their tier assignments — is managed through CVS Caremark. Tier placement determines your cost-sharing: Tier 1 generics carry the lowest copay, while Tier 3-4 specialty and brand medications may require prior authorization (PA), step therapy (trying lower-cost alternatives first), or have higher cost-sharing requirements.

Coverage for specific weight loss medications in Connecticut Aetna plans typically depends on your plan’s formulary, your body mass index (BMI), and whether required clinical criteria are met. Below is a general overview of how Aetna through CVS Caremark typically handles common weight loss medications — verify your specific benefits before making any treatment decisions.

GLP-1 Receptor Agonists for Weight Loss

Wegovy (semaglutide 2.4 mg) is the FDA-approved GLP-1 receptor agonist indicated specifically for chronic weight management. On Aetna commercial plans in Connecticut, Wegovy typically falls at Tier 3 or Tier 4 and requires prior authorization. Common criteria include a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Step therapy — demonstrating that lower-cost alternatives were tried or are clinically inappropriate — may also be required before approval is granted.

Zepbound (tirzepatide 2.5–15 mg), the FDA-approved GIP/GLP-1 dual agonist for weight management, is covered on a plan-specific basis. Tier placement and prior authorization criteria vary. Some Aetna commercial plans in Connecticut cover Zepbound at Tier 3-4 with PA; others may not include it on formulary. Checking your Explanation of Benefits or calling the CVS Caremark number on your card is the most reliable way to confirm coverage before prescribing begins.

Important note on Ozempic and Mounjaro: Ozempic (semaglutide 0.5–2 mg) and Mounjaro (tirzepatide 2.5–15 mg) are FDA-approved for type 2 diabetes management, not for weight loss as the primary indication. Most Aetna plans in Connecticut will not approve Ozempic or Mounjaro solely for weight management — prior authorization requests citing obesity without a concurrent diabetes diagnosis are typically denied. Patients with both type 2 diabetes and obesity may have a different coverage picture; a Klarity provider can help assess your clinical situation.

Saxenda (liraglutide 3 mg)

Saxenda is an FDA-approved daily injectable GLP-1 receptor agonist for chronic weight management. On Aetna plans in Connecticut, Saxenda typically falls at Tier 3 and requires prior authorization plus step therapy. Because weekly GLP-1 injectables such as Wegovy are now available, step therapy may require trying Saxenda before Wegovy, or vice versa — plan documents define the sequence. Coverage requires meeting BMI criteria similar to Wegovy.

Phentermine

Phentermine is the most widely prescribed short-term weight loss medication in the United States and is a Schedule IV controlled substance. On most Aetna Connecticut plans through CVS Caremark, generic phentermine typically falls at Tier 1 or Tier 2 with no prior authorization required, though quantity limits of a 30-day supply per fill apply due to its Schedule IV classification. This makes phentermine one of the most accessible prescription weight loss options for patients who qualify and have no contraindications.

Qsymia (phentermine/topiramate extended-release)

Qsymia is an FDA-approved combination weight loss medication combining phentermine with extended-release topiramate. As a Schedule IV controlled substance, it is subject to a 30-day supply limit per fill. On Aetna plans in Connecticut, Qsymia typically falls at Tier 3-4 and requires prior authorization plus step therapy, which usually means demonstrating that simpler weight loss interventions were tried first. Topiramate’s teratogenic risk means Aetna may also require documentation of negative pregnancy status or contraceptive use in patients of childbearing potential.

Contrave (naltrexone/bupropion extended-release)

Contrave is a non-controlled combination of naltrexone and bupropion extended-release, FDA-approved for chronic weight management. On Aetna Connecticut plans, Contrave typically falls at Tier 3-4 and requires prior authorization and step therapy. An important clinical consideration: because Contrave contains bupropion, it is contraindicated in patients currently taking monoamine oxidase inhibitors (MAOIs) and requires caution in patients with seizure disorders or those concurrently taking other bupropion-containing medications such as Wellbutrin. Klarity providers screen for these contraindications as part of the intake process.

Orlistat (Alli/Xenical)

Orlistat is a non-systemic lipase inhibitor available over the counter (Alli, 60 mg) and by prescription (Xenical, 120 mg). Prescription orlistat through CVS Caremark on Aetna plans in Connecticut is typically placed at a low tier with no prior authorization required, making it one of the easier medications to access — though many patients prefer GLP-1 options due to greater efficacy and tolerability.

What Prior Authorization Typically Requires for Aetna Weight Loss Coverage

For GLP-1 medications and other higher-tier weight loss drugs, Aetna’s prior authorization process through CVS Caremark typically requires the prescribing provider to document: (1) current BMI meeting threshold criteria; (2) at least one weight-related comorbidity if BMI is below 30; (3) evidence that the patient has participated in or been counseled regarding lifestyle modifications such as diet and exercise; and (4) for step therapy requirements, documentation that a prior medication was tried, was ineffective, or is clinically contraindicated.

Klarity Health providers are experienced with this documentation process. Because Klarity operates independently of Aetna’s in-network telehealth platform Teladoc Health, Klarity’s network status varies by plan — checking your specific plan’s provider directory or calling the member services number on your Aetna card before your first appointment is recommended to understand your out-of-network cost-sharing obligations.

Check if your Aetna plan may cover weight loss treatment in Connecticut →

See if you may qualify for online weight loss treatment at Klarity Health →

How Klarity Health Supports Weight Loss Treatment in Connecticut

Klarity Health connects patients in Connecticut with licensed providers — including physicians, nurse practitioners, and physician assistants — who specialize in medically supervised weight management. With 2,000+ licensed providers in our network, Klarity patients can typically book an initial telehealth consultation quickly without long wait times.

A Klarity provider can: evaluate your weight loss goals and medical history; order relevant labs (HbA1c, lipid panel, thyroid function) to rule out contributing conditions; prescribe FDA-approved weight loss medications where clinically appropriate; submit prior authorization documentation to your insurer; and support you with ongoing follow-up and medication management through a secure telehealth platform.

Because Klarity is independent of Teladoc Health — Aetna’s preferred telehealth partner — some Aetna plans in Connecticut may apply out-of-network cost-sharing to Klarity visits. Your plan’s Summary of Benefits and Coverage (SBC) or a call to the member services number on your Aetna card will confirm whether Klarity providers participate in your specific network.

Frequently Asked Questions

Does Connecticut’s parity law (CGS § 38a-514b) require Aetna to cover weight loss medications?

CGS § 38a-514b requires that behavioral health benefits be provided at parity with medical and surgical benefits. It does not create a standalone mandate for weight loss medication coverage. However, patients with concurrent behavioral health diagnoses — such as binge eating disorder, depression, or anxiety disorders — may have additional protections under parity law for the behavioral health component of their treatment. If you believe parity protections apply to your situation and Aetna has denied coverage, you can file a complaint with the Connecticut Insurance Department at 1-800-203-3447.

My Aetna coverage is through my employer. Does Connecticut parity law apply?

If your employer self-funds the health plan and Aetna administers it, the plan is governed by ERISA federal law, not Connecticut state insurance law. CGS § 38a-514b does not apply to ERISA-governed plans. Federal MHPAEA protections apply instead, but MHPAEA’s scope for weight loss specifically is narrower than many patients expect. Your plan’s Summary Plan Description (SPD) is the authoritative document. If you are enrolled through Access Health CT in an individual or small-group plan, Connecticut state law does apply.

Is Wegovy covered by Aetna in Connecticut?

Coverage for Wegovy varies by Aetna plan in Connecticut. Wegovy typically requires prior authorization on Aetna commercial plans, with BMI criteria and potential step therapy requirements. Some employer-sponsored plans explicitly exclude anti-obesity medications, which would override standard formulary coverage. Verify your specific plan’s benefits through the CVS Caremark portal or by calling member services before scheduling a Wegovy consultation.

What is the difference between Ozempic and Wegovy for insurance purposes?

Ozempic and Wegovy both contain semaglutide, but they are FDA-approved for different indications and have different formulary classifications. Ozempic (approved for type 2 diabetes) is typically covered under diabetes medication benefits. Wegovy (approved for chronic weight management) is covered under weight management benefits — a different benefit category with different PA criteria. Aetna does not approve Ozempic for weight management as the primary indication in Connecticut. A provider must specify the correct indication when submitting a prior authorization request.

What is Access Health CT?

Access Health CT is Connecticut’s official health insurance marketplace established under the Affordable Care Act. Residents can purchase individual and family plans through Access Health CT, and qualifying individuals may be eligible for premium tax credits and cost-sharing reductions. Plans purchased through Access Health CT are subject to Connecticut insurance regulations including CGS § 38a-514b parity requirements. You can learn more at accesshealthct.com or call 1-855-805-4325.

Is Klarity Health in-network with Aetna in Connecticut?

Klarity Health operates independently of Teladoc Health, which is Aetna’s preferred in-network telehealth platform for many commercial plans. Klarity’s network participation varies by plan. We recommend calling the member services number on your Aetna insurance card or checking your online member portal to confirm Klarity’s status in your specific plan before your first visit. Some patients choose to see Klarity providers as out-of-network and submit for reimbursement — your plan’s out-of-network cost-sharing terms will determine what you pay.

Start Your Weight Loss Journey With Klarity Health

Whether you’re exploring GLP-1 medications, phentermine, or another clinically appropriate weight loss treatment, Klarity Health’s licensed providers in Connecticut can help you navigate your Aetna coverage and develop a personalized treatment plan.

Check if your Aetna plan may cover weight loss treatment in Connecticut →

See if you may qualify for online weight loss treatment at Klarity Health →

Disclaimer: Insurance coverage for weight loss treatment varies by plan, employer group, and individual circumstances. Nothing on this page constitutes a guarantee of coverage. Patients should verify their specific benefits with Aetna or their plan administrator before booking an appointment. For questions about your Connecticut insurance rights, contact the Connecticut Insurance Department at 1-800-203-3447.